Published in Am J Cardiol on June 07, 2013
Hypertrophic cardiomyopathy: a heart in need of an energy bar? Front Physiol (2014) 0.82
Creatine kinase rate constant in the human heart measured with 3D-localization at 7 tesla. Magn Reson Med (2016) 0.78
Principals and clinical applications of magnetic resonance cardiac spectroscopy in heart failure. Heart Fail Rev (2017) 0.77
Clinical Genetic Testing for the Cardiomyopathies and Arrhythmias: A Systematic Framework for Establishing Clinical Validity and Addressing Genotypic and Phenotypic Heterogeneity. Front Cardiovasc Med (2016) 0.76
Linking myofilaments to sudden cardiac death: recent advances. J Physiol (2017) 0.75
Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr (2005) 46.32
Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr (1990) 25.24
Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol (1986) 18.40
Hypertrophic cardiomyopathy: a systematic review. JAMA (2002) 9.15
Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr (2009) 7.69
A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell (1990) 5.77
Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res (2004) 3.72
Energy metabolism in heart failure and remodelling. Cardiovasc Res (2008) 2.37
ATP flux through creatine kinase in the normal, stressed, and failing human heart. Proc Natl Acad Sci U S A (2005) 2.17
Preclinical diagnosis of familial hypertrophic cardiomyopathy by genetic analysis of blood lymphocytes. N Engl J Med (1991) 2.11
The creatine kinase system in normal and diseased human myocardium. N Engl J Med (1985) 2.06
31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. Circulation (1998) 2.06
Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy. J Clin Invest (1998) 1.94
Altered creatine kinase adenosine triphosphate kinetics in failing hypertrophied human myocardium. Circulation (2006) 1.84
Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction. J Biol Chem (1994) 1.77
Coupling of cell energetics with membrane metabolic sensing. Integrative signaling through creatine kinase phosphotransfer disrupted by M-CK gene knock-out. J Biol Chem (2002) 1.72
Segmental and global longitudinal strain and strain rate based on echocardiography of 1266 healthy individuals: the HUNT study in Norway. Eur J Echocardiogr (2009) 1.69
Allopurinol acutely increases adenosine triphospate energy delivery in failing human hearts. J Am Coll Cardiol (2012) 1.66
Four-angle saturation transfer (FAST) method for measuring creatine kinase reaction rates in vivo. Magn Reson Med (2002) 1.58
The in vitro motility activity of beta-cardiac myosin depends on the nature of the beta-myosin heavy chain gene mutation in hypertrophic cardiomyopathy. J Muscle Res Cell Motil (1997) 1.40
Role of MgADP in the development of diastolic dysfunction in the intact beating rat heart. J Clin Invest (1997) 1.36
Some new aspects of creatine kinase (CK): compartmentation, structure, function and regulation for cellular and mitochondrial bioenergetics and physiology. Biofactors (1998) 1.32
The cytoplasmic phosphorylation potential. Its possible role in the control of myocardial respiration and cardiac contractility. J Mol Cell Cardiol (1985) 1.31
Human cardiac high-energy phosphate metabolite concentrations by 1D-resolved NMR spectroscopy. Magn Reson Med (1996) 1.17
Phosphate metabolite imaging and concentration measurements in human heart by nuclear magnetic resonance. Magn Reson Med (1990) 1.15
Correcting reaction rates measured by saturation-transfer magnetic resonance spectroscopy. J Magn Reson (2007) 0.99
Influence of aging or left ventricular hypertrophy on the human heart: contents of phosphorus metabolites measured by 31P MRS. Magn Reson Med (1998) 0.91
Differences in cardiac energetics between patients with familial and nonfamilial hypertrophic cardiomyopathy. Circulation (2000) 0.83
Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation (2007) 5.09
Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res (2004) 3.72
Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med (2006) 3.59
Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol (2008) 2.99
The performance of interventional loopless MRI antennae at higher magnetic field strengths. Med Phys (2008) 2.97
Towards real-time intravascular endoscopic magnetic resonance imaging. JACC Cardiovasc Imaging (2010) 2.96
Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation (2005) 2.80
Cardiac magnetic resonance assessment of dyssynchrony and myocardial scar predicts function class improvement following cardiac resynchronization therapy. JACC Cardiovasc Imaging (2008) 2.64
Combined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low risk for defibrillator firings and death. Circ Cardiovasc Imaging (2012) 2.62
Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart. Circulation (2008) 2.37
Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla. Circulation (2006) 2.36
Two-dimensional strain--a Doppler-independent ultrasound method for quantitation of regional deformation: validation in vitro and in vivo. J Am Soc Echocardiogr (2005) 2.20
ATP flux through creatine kinase in the normal, stressed, and failing human heart. Proc Natl Acad Sci U S A (2005) 2.17
Electrophysiological consequences of dyssynchronous heart failure and its restoration by resynchronization therapy. Circulation (2009) 2.09
Noninvasive visualization of coronary artery endothelial function in healthy subjects and in patients with coronary artery disease. J Am Coll Cardiol (2010) 2.09
Impact of arterial load and loading sequence on left ventricular tissue velocities in humans. J Am Coll Cardiol (2007) 2.05
A prototype RF dosimeter for independent measurement of the average specific absorption rate (SAR) during MRI. J Magn Reson Imaging (2007) 1.90
Altered creatine kinase adenosine triphosphate kinetics in failing hypertrophied human myocardium. Circulation (2006) 1.84
Quantitative cardiac 31P spectroscopy at 3 Tesla using adiabatic pulses. Magn Reson Med (2009) 1.83
Tissue sodium concentration in human brain tumors as measured with 23Na MR imaging. Radiology (2003) 1.77
Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2008) 1.75
Reversal of global apoptosis and regional stress kinase activation by cardiac resynchronization. Circulation (2008) 1.67
Allopurinol acutely increases adenosine triphospate energy delivery in failing human hearts. J Am Coll Cardiol (2012) 1.66
Impaired ATP kinetics in failing in vivo mouse heart. Circ Cardiovasc Imaging (2010) 1.63
Mechanisms of enhanced beta-adrenergic reserve from cardiac resynchronization therapy. Circulation (2009) 1.63
Independent predictors of survival in primary systemic (Al) amyloidosis, including cardiac biomarkers and left ventricular strain imaging: an observational cohort study. J Am Soc Echocardiogr (2010) 1.62
Cardiac resynchronization by cardiosphere-derived stem cell transplantation in an experimental model of myocardial infarction. J Am Soc Echocardiogr (2011) 1.61
Fluorine (19F) MRS and MRI in biomedicine. NMR Biomed (2010) 1.60
Four-angle saturation transfer (FAST) method for measuring creatine kinase reaction rates in vivo. Magn Reson Med (2002) 1.58
Off-resonance angiography: a new method to depict vessels--phantom and rabbit studies. Radiology (2008) 1.56
ECG quantification of myocardial scar in cardiomyopathy patients with or without conduction defects: correlation with cardiac magnetic resonance and arrhythmogenesis. Circ Arrhythm Electrophysiol (2008) 1.55
Cardiac resynchronization therapy corrects dyssynchrony-induced regional gene expression changes on a genomic level. Circ Cardiovasc Genet (2009) 1.51
Right, but not left, bundle branch block is associated with large anteroseptal scar. J Am Coll Cardiol (2013) 1.45
MRI endoscopy using intrinsically localized probes. Med Phys (2009) 1.45
Noise figure limits for circular loop MR coils. Magn Reson Med (2009) 1.44
Influence of atrial function and mechanical synchrony on LV hemodynamic status in heart failure patients on resynchronization therapy. JACC Cardiovasc Imaging (2011) 1.41
Proton magnetic resonance spectroscopic imaging of human breast cancer: a preliminary study. J Magn Reson Imaging (2004) 1.40
Cardiac MRI scar patterns differ by sex in an implantable cardioverter-defibrillator and cardiac resynchronization therapy cohort. Heart Rhythm (2013) 1.40
Magnetic resonance Spectroscopy with Linear Algebraic Modeling (SLAM) for higher speed and sensitivity. J Magn Reson (2012) 1.37
Noninvasive detection of macrophage-rich atherosclerotic plaque in hyperlipidemic rabbits using "positive contrast" magnetic resonance imaging. J Am Coll Cardiol (2008) 1.35
A multichannel, real-time MRI RF power monitor for independent SAR determination. Med Phys (2012) 1.33
The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2012) 1.32
Magnetic resonance imaging assessment of ventricular dyssynchrony: current and emerging concepts. J Am Coll Cardiol (2005) 1.32
Creatine kinase-mediated improvement of function in failing mouse hearts provides causal evidence the failing heart is energy starved. J Clin Invest (2011) 1.26
Elevated tissue sodium concentration in malignant breast lesions detected with non-invasive 23Na MRI. Breast Cancer Res Treat (2007) 1.21
Skeletal muscle ATP kinetics are impaired in frail mice. Age (Dordr) (2013) 1.18
Coronary magnetic resonance angiography. J Magn Reson Imaging (2007) 1.18
Vascular abnormalities in primary amyloidosis. Eur Heart J (2007) 1.13
Monitoring and correcting spatio-temporal variations of the MR scanner's static magnetic field. MAGMA (2006) 1.13
Reduced myocardial creatine kinase flux in human myocardial infarction: an in vivo phosphorus magnetic resonance spectroscopy study. Circulation (2009) 1.13
Large field-of-view real-time MRI with a 32-channel system. Magn Reson Med (2004) 1.13
Echocardiography in hypertrophic cardiomyopathy: the role of conventional and emerging technologies. JACC Cardiovasc Imaging (2008) 1.12
Triple repetition time saturation transfer (TRiST) 31P spectroscopy for measuring human creatine kinase reaction kinetics. Magn Reson Med (2010) 1.09
Metabolic rates of ATP transfer through creatine kinase (CK Flux) predict clinical heart failure events and death. Sci Transl Med (2013) 1.08
Quantifying in vivo MR spectra with circles. J Magn Reson (2005) 1.08
Computational method for identifying and quantifying shape features of human left ventricular remodeling. Ann Biomed Eng (2009) 1.08
Galphas-biased beta2-adrenergic receptor signaling from restoring synchronous contraction in the failing heart. Sci Transl Med (2011) 1.08
Measuring human cardiac tissue sodium concentrations using surface coils, adiabatic excitation, and twisted projection imaging with minimal T2 losses. J Magn Reson Imaging (2005) 1.08
Letter by Yalcin et al regarding article, "Left ventricular wall thickness and the presence of asymmetric hypertrophy in healthy young army recruits: data from the LARGE Heart Study". Circ Cardiovasc Imaging (2013) 1.07
Local planar gradients with order-of-magnitude strength and speed advantage. Magn Reson Med (2007) 1.06
TGFbeta inducible early gene-1 (TIEG1) and cardiac hypertrophy: Discovery and characterization of a novel signaling pathway. J Cell Biochem (2007) 1.06
Noninvasive imaging in cardiac resynchronization therapy--part 1: selection of patients. Pacing Clin Electrophysiol (2008) 1.06
Detection of left ventricular systolic dysfunction in cardiac amyloidosis with strain rate echocardiography. J Am Soc Echocardiogr (2007) 1.05
Evidence of impaired left ventricular systolic function by Doppler myocardial imaging in patients with systemic amyloidosis and no evidence of cardiac involvement by standard two-dimensional and Doppler echocardiography. Am J Cardiol (2008) 1.05
Xanthine oxidase inhibitors improve energetics and function after infarction in failing mouse hearts. Am J Physiol Heart Circ Physiol (2005) 1.04
On restoring motion-induced signal loss in single-voxel magnetic resonance spectra. Magn Reson Med (2006) 1.04
Reproducibility of 3D free-breathing magnetic resonance coronary vessel wall imaging. Eur Heart J (2005) 1.04
Lumped-element planar strip array (LPSA) for parallel MRI. Magn Reson Med (2004) 1.04
Contribution of central adiposity to left ventricular diastolic function (from the Baltimore Longitudinal Study of Aging). Am J Cardiol (2012) 1.03
Highly-accelerated quantitative 2D and 3D localized spectroscopy with linear algebraic modeling (SLAM) and sensitivity encoding. J Magn Reson (2013) 1.03
Strain and strain rate echocardiography. Curr Opin Cardiol (2002) 1.01
Feasibility and variability of three dimensional echocardiography in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Am J Cardiol (2006) 1.00
Usefulness of two-dimensional speckle strain for evaluation of left ventricular diastolic deformation in patients with coronary artery disease. Am J Cardiol (2006) 1.00
Comparison of usefulness of echocardiographic Doppler variables to left ventricular end-diastolic pressure in predicting future heart failure events. Am J Cardiol (2006) 0.99
Correcting reaction rates measured by saturation-transfer magnetic resonance spectroscopy. J Magn Reson (2007) 0.99
Pathophysiological mechanisms underlying ventricular dyssynchrony. Europace (2009) 0.99
Left atrial myopathy in cardiac amyloidosis: implications of novel echocardiographic techniques. Eur Heart J (2004) 0.98
Abnormal energetics and ATP depletion in pressure-overload mouse hearts: in vivo high-energy phosphate concentration measures by noninvasive magnetic resonance. Am J Physiol Heart Circ Physiol (2009) 0.97
Interventional loopless antenna at 7 T. Magn Reson Med (2011) 0.97
Comparison of novel echocardiographic parameters of right ventricular function with ejection fraction by cardiac magnetic resonance. J Am Soc Echocardiogr (2007) 0.97
Interventional MRI: tapering improves the distal sensitivity of the loopless antenna. Magn Reson Med (2010) 0.96
Strain rate and strain: a step-by-step approach to image and data acquisition. J Am Soc Echocardiogr (2004) 0.95
7 Tesla MRI with a transmit/receive loopless antenna and B1-insensitive selective excitation. Magn Reson Med (2013) 0.95
Tissue sodium concentration in myocardial infarction in humans: a quantitative 23Na MR imaging study. Radiology (2008) 0.94
Doppler myocardial imaging for early detection of right ventricular dysfunction in patients with pulmonary hypertension. J Am Soc Echocardiogr (2008) 0.93